Rachel Greenberg, MD, will present her randomized clinical trial, “Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia,” which examines the safety profile of furosemide in preterm infants at high risk for bronchopulmonary dysplasia. The session will explore trial design, key outcomes, and how these findings inform everyday clinical decision-making in the NICU, followed by expert panel discussion from Anna Maria Hibbs, MD, Nicolas Bamat, MD, Colm Travers, MD, and Matthew Kielt, MD.
PEDS Journal Club: Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia
-
When
Friday, March 6 2:00 pm — 3:00 pm EST -
Where
Online -
Type
Assembly Webinars & Podcasts
Note:
Outlook Live is for personal accounts (e.g., @outlook.com, @hotmail.com, @live.com), while Office 365 is for work accounts via Microsoft 365.